| ELANCO ANIMAL HEALTH. |
| USA |
| Gesundheit |
| US28414H1032 / A2N6BH |
| 5EA (Frankfurt) / ELAN (NYSE) |
| FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN |
| - |
| https://www.elanco.com/ |
|
Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to prevent and treat diseases in both companion anim..
>Volltext.. |
| 11340.55 Mio. EUR |
| 14427.9 Mio. EUR |
| 4281.35 Mio. EUR |
| 867.12 Mio. EUR |
| -211.75 Mio. EUR |
| -0.43 EUR |
| 3492.1 Mio. EUR |
| 374.5 Mio. EUR |
| 504.87 Mio. EUR |
| 0.26 |
| 3.49% |
| -160.75% |
| - |
| - |
| - |
| - |
| ELANCO |
| 17.07.26 |
|
||||
|
||||
|